MedPath

SINUSITIS RELIEF

SINUSITIS RELIEF

Discontinued
DIN Number

02236923

Drug Class

Human

Market Date

Nov 21, 1997

Company
HC

jamieson laboratories ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02236923
AIG Number1131866001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification92:01.00*
Health Canada Classification

ACTIVE INGREDIENTS (11)

ANEMARRHENA RHIZOMEActive
Strength: 29.2 MG / CAP
Monograph: ANEMARRHENA RHIZOME
ANGELICA ROOTActive
Strength: 29.2 MG / CAP
Monograph: ANGELICA ROOT
BUPLEURUM CHINENSE DCActive
Strength: 12.25 MG / CAP
Monograph: BUPLEURUM CHINENSE DC
CENTIPEDA MINIMAActive
Strength: 63.1 MG / CAP
Monograph: CENTIPEDA MINIMA
CHRYSANTHEMUM MORIFOLIAActive
Strength: 57.5 MG / CAP
Monograph: CHRYSANTHEMUM MORIFOLIA
CINNAMOMUM ZEYLANICUMActive
Strength: 12.25 MG / CAP
Monograph: CINNAMOMUM ZEYLANICUM
COCKLEBURActive
Strength: 68.75 MG / CAP
Monograph: COCKLEBUR
EPHEDRINE RACEMIC (EPHEDRA)Active
Strength: 1.07 MG / CAP
Monograph: EPHEDRINE RACEMIC (EPHEDRA)
FIELD MINT LEAFActive
Strength: 12.25 MG / CAP
Monograph: FIELD MINT LEAF
GLYCYRRHIZA URALENSISActive
Strength: 12.25 MG / CAP
Monograph: GLYCYRRHIZA URALENSIS
RADIX LEDEBOURIELLA SESELOIDESActive
Strength: 29.2 MG / CAP
Monograph: RADIX LEDEBOURIELLA SESELOIDES

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.